Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection
- 24 April 2002
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 4 (5) , 463-469
- https://doi.org/10.1002/jgm.267
Abstract
Background Transduction of the murine retinal pigmented epithelium (RPE) with adenovirus vectors requires technically difficult and invasive subretinal injections. This study tested the hypothesis that recombinant vectors based on feline immunodeficiency virus (FIV) could access the retina following intravitreal injection. Methods FIV vectors expressing E. coli β-galactosidase (FIVβgal) were injected alone, or in combination with adenovirus vectors expressing eGFP, into the vitreous of normal mice and eyes evaluated for transgene expression. In further studies, the utility of FIV-mediated gene transfer to correct lysosomal storage defects in the anterior and posterior chambers of eyes was tested using recombinant FIV vectors expressing β-glucuronidase. FIVβgluc vectors were injected into β-glucuronidase-deficient mice, an animal model of mucopolysacharridoses type VII. Results The results of this study show that similar to adenovirus, both corneal endothelium and cells of the iris could be transduced following intravitreal injection of FIVβgal. However, in contrast to adenovirus, intravitreal injection of FIVβgal also resulted in transduction of the RPE. Immunohistochemistry following an intravitreal injection of an AdeGFP (adenovirus expressing green fluorescent protein) and FIVβgal mixture confirmed that both viruses mediated transduction of corneal endothelium and cells of the iris, while only FIVβgal transduced cells in the retina. Using the β-glucuronidase-deficient mouse, the therapeutic efficacy of intravitreal injection of FIVβgluc (FIV expressing β-glucuronidase) was tested. Intravitreal injection of FIVβgluc to the eyes of β-glucuronidase-deficient mice resulted in rapid reduction (within 2 weeks) of the lysosomal storage defect within the RPE, corneal endothelium, and the non-pigmented epithelium of the ciliary process. Transgene expression and correction of the lysosomal storage defect remained for at least 12 weeks, the latest time point tested. Conclusion These studies demonstrate that intravitreal injection of FIV-based vectors can mediate efficient and lasting transduction of cells in the cornea, iris, and retina. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucomaGene Therapy, 1999
- A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cellsGene Therapy, 1998
- Adeno-Associated Virus Gene Transfer to Mouse RetinaHuman Gene Therapy, 1998
- Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.Journal of Clinical Investigation, 1997
- Corneal Endothelium in Mucopolysaccharide Storage DisordersCornea, 1996
- Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer.Proceedings of the National Academy of Sciences, 1995
- Cross-Correction of β-Glucuronidase Deficiency by Retroviral Vector-Mediated Gene TransferExperimental Cell Research, 1994
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.Journal of Clinical Investigation, 1989
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973